Opportunity FeedHalewood Diagnostics
Halewood Diagnostics (HLWD)
Public equity · Medical devices
71/100
▼ -3 vs prior
CandidateFresh · observed 27h ago
Conviction governance
✓ Evidence convergence: 3 corroborating families (2+ required)✓ Adversarial review completerun-2026-08-27-004▲ 1 unresolved critical contradictionscvd-hlwd-2026-08-27-01 · conviction-policy 1.0
Promotion blocked: Receivables growing 2× revenue (con-hlwd-recv) is unresolved — promotion blocked.
Dossier not yet generated
This candidate is in the candidate tier. A full dossier (theses, evidence, skeptic review) is produced when the research orchestrator promotes it — no model run has been scheduled yet.
- quality: 66 of 100 — independently corroborating
- growth: 80 of 100 — independently corroborating
- valuation: 58 of 100
- ownership: 63 of 100
- catalysts: 77 of 100 — independently corroborating
- risk: 44 of 100